Although the statistical methods enabling efficient adaptive seamless designs are increasingly well established, it is important to continue to use the endpoints and specifications that best suit the therapy area and stage of development concerned when conducting such a trial. Approaches exist that allow adaptive designs to continue seamlessly either in a subpopulation of patients or in the whole population on the basis of data obtained from the first stage of a phase II/III design: our proposed design adds extra flexibility by also allowing the trial to continue in all patients but with both the subgroup and the full population as co-primary populations. Further, methodology is presented which controls the Type-I error rate at less than 2.5% when the phase II and III endpoints are different but correlated time-to-event endpoints. The operating characteristics of the design are described along with a discussion of the practical aspects in an oncology setting.
It is not uncommon to set the sample size in a clinical trial to attain specified power at a value for the treatment effect deemed likely by the experimenters, even though a smaller treatment effect would still be clinically important. Recent papers have addressed the situation where such a study produces only weak evidence of a positive treatment effect at an interim stage and the organizers wish to modify the design in order to increase the power to detect a smaller treatment effect than originally expected. Raising the power at a small treatment effect usually leads to considerably higher power than was first specified at the original alternative. Several authors have proposed methods which are not based on sufficient statistics of the data after the adaptive redesign of the trial. We discuss these proposals and show in an example how the same objectives can be met while maintaining the sufficiency principle, as long as the eventuality that the treatment effect may be small is considered at the design stage. The group sequential designs we suggest are quite standard in many ways but unusual in that they place emphasis on reducing the expected sample size at a parameter value under which extremely high power is to be achieved. Comparisons of power and expected sample size show that our proposed methods can out-perform L. Fisher's 'variance spending' procedure. Although the flexibility to redesign an experiment in mid-course may be appealing, the cost in terms of the number of observations needed to correct an initial design may be substantial.
SUMMARY
Assuming a smooth trend plus independent error model for the environmental effects in the yields of a field plot experiment, least squares smoothing methods are developed to estimate both the treatment effects and the unknown trend. Treatment estimates are closely related to those resulting from a generalized least squares analysis in which the covariance structure for the environmental effects has a particular form. However, the main emphases are on the accuracy of treatment estimates under a fixed smooth trend plus error model and the exploratory power of the basic method to isolate trend effects of unknown form.
Although the detailed development is for the one‐dimensional case, generalizations of the smoothness concept and extensions to two dimensions are also discussed.
Application of the basic method is illustrated on three data sets and the results compared with other analyses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.